Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| Andrew Herr, PHD | Studies of metal dependent intercellular adhesion in staphylococcal biofilms | National Institutes of Health (NIH) | 2R01GM094363-06A1 | 07/01/2019 - 06/30/2020 | $339,112 |
| Andrew Herr, PHD | Wimpy antibody isotypes protect against antibody-mediate | University of Cincinnati (National Institutes of Health) | R01AI130103 | 01/01/2020 - 12/31/2020 | $111,523 |
| Andrew Herr, PHD | Rapid, safe suppression of IgE-mediated disease with monovalent anti-FceRIa mAb | University of Cincinnati (National Institutes of Health) | 012329-002 | 07/01/2019 - 06/30/2020 | $111,523 |
| Chandrashekhar Pasare DVM | Innate mechanisms of regulation of memory TH17 cell response | National Institutes of Health (NIH) | 0001162 | 12/01/2019 - 11/30/2020 | $397,500 |
| Chandrashekhar Pasare DVM | Endocytic trafficking and cell signaling in models of ARC syndrome | The University of Texas Southwestern (National Institutes of Health) | 0001239 | 04/01/2019 - 03/31/2020 | $166,050 |
| Chandrashekhar Pasare DVM | (PQ10) Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer | The University of Texas Southwestern (National Institutes of Health) | GMO 20111 | 09/01/2019 - 08/31/2020 | $171,598 |
| Claire A Chougnet, PHD | Prenatal inflammatory exposures and neonatal immune deve | National Institutes of Health (NIH) | U01ES029234 | 09/01/2019 - 08/31/2020 | $536,587 |
| Claire A Chougnet, PHD | Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases | UCLA School of Public Health (National Institutes of Health) | R01HD098389 | 06/01/2019 - 03/31/2020 | $119,217 |
| Claire A Chougnet, PHD David A Hildeman, PHD |
Metabolic alterations in age-associated dendritic cell dysfunction | National Institutes of Health (NIH) | 1R01AG053498-01A1 | 03/01/2020 - 02/28/2021 | $690,478 |
| Claire A Chougnet, PHD David A Hildeman, PHD |
Homeostasis and function of regulatory T cells in aging | National Institutes of Health (NIH) | R56AG033057 | 09/01/2019 - 08/31/2020 | $643,474 |
| David A Hildeman, PHD | PEARL: Pathway Exploration and Analysis in Renal Lupus | Feinstein Institute for Medical Research (National Institutes of Health) | UH2AR067688 Hildeman | 06/01/2019 - 05/31/2020 | $104,481 |
| David A Hildeman, PHD | Pathogenesis and therapeutic targeting of immune disorde | National Institutes of Health (NIH) | T32AI118697-01A1 | 07/01/2019 - 06/30/2020 | $141,626 |
| David A Hildeman, PHD | Single cell analysis of transplant rejection | National Institutes of Health (NIH) | R21AI142264 | 12/01/2019 - 11/30/2020 | $199,026 |
| David A Hildeman PhD |
Ionic Mechanisms of Resistance to Immunotherapy in Head | Department of Defense | W81XWH-17-1-0378 | 07/01/2019 - 06/30/2020 | $173,160 |
| Emily M Eshleman, PHD | Epithelial antigen presentation in regulation of the host-microbiota relationship | National Institutes of Health (NIH) | F32AI147591 | 04/01/2020 - 03/31/2021 | $65,310 |
| Harry Leighton Grimes, PHD | Defining the landscape of pediatric AML vulnerabilities | Cancer Free Kids | CFK Grimes FY20 | 07/15/2019 - 07/14/2020 | $50,000 |
| Harry Leighton Grimes, PHD | Defining human hematopoietic cells via transcriptomes and methods to isolate them | National Institutes of Health (NIH) | 1R21HL150678-01 | 01/01/2020 - 12/31/2020 | $198,750 |
| Harry Leighton Grimes, PHD | Mechanisms of granulocyte homeostasis | National Institutes of Health (NIH) | R01HL122661 | 04/01/2020 - 03/31/2021 | $592,095 |
| Harry Leighton Grimes, PHD Marie-Dominique Filippi, PHD |
Regulation of functionally discrete hematopietic stem cells | National Institutes of Health (NIH) | R01DK121062 | 03/12/2020 - 12/31/2020 | $296,035.50 |
| Ian P Lewkowich | Study of Activity-Dependent Sympathetic Sprouting | University of Cincinnati (National Institutes of Health) | 010133-007 | 02/01/2019 - 01/31/2020 | $8,332 |
| Ian P Lewkowich Satoshi Namekawa, PHD |
Preconceptual paternal environmental allergen exposure, sperm epigenetics and offspring asthma development | National Institutes of Health (NIH) | R21AI152100 | 03/06/2020 - 02/28/2021 | $99,375 |
| Ian P Lewkowich Senad Divanovic, PHD |
Obesity, Metabolic Syndrome and Asthma | National Institutes of Health (NIH) | R21AI139829 | 12/01/2019 - 11/30/2020 | $238,500 |
| Jonathan D Katz, PHD | Manipulating DNA Damage-response Signaling for the Treatment of Type 1 Diabetes | National Institutes of Health (NIH) | R01DK117632 | 01/01/2020 - 12/31/2020 | $402,111 |
| Maria Eugenia Fields, PHD | Pathogenic potential of Th17 axis in obesity-associated sequelae | American Diabetes Association | ADA Fields - Divanov | 07/01/2019 - 06/30/2020 | $59,412 |
| Michael B Jordan, MD | Targeted manipulation of the DNA damage response for prevention/treatment of GVHD | National Institutes of Health (NIH) | R21AI142266 | 12/01/2019 - 11/30/2020 | $198,750 |
| Senad Divanovic, PHD | Immunopathogenesis of non-alcoholic fatty liver disease | National Institutes of Health (NIH) | R01DK099222 | 09/18/2019 - 07/31/2020 | $550,978 |
| Theresa Alenghat | Microbiota-sensitive epigenetic regulation of IBD | Kenneth Rainin Foundation | KRF_Alenghat | 10/01/2019 - 09/30/2020 | $200,000 |
| Theresa Alenghat | Host integration of commensal and pathogenic bacterial-derived signals | National Institutes of Health (NIH) | R01DK116868 | 06/01/2019 - 05/31/2020 | $91,764 |
| Theresa Alenghat | Dietary regulation of innate intestinal immunity | University of Cincinnati (Burroughs Wellcome Foundation) | BWF_Alenghat | 07/01/2019 - 06/30/2020 | $100,000 |
| Current Year Direct | $7,056,767.50 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| David A Hildeman, PHD | Novartis Pharmaceuticals | $400,001.00 |
| Total Annual Industry Award Dollars | $400,001.00 | |
